This symposium is funded through an educational grant from Bracco Diagnostics.

A breakfast symposium conducted at the 49th ASHP Midyear Clinical Meeting and Exhibition

Institute for Safe Medication Practices (ISMP) 200 Lakeside Drive, Suite 200, Horsham, PA 19044 Phone: (215) 947-7797 www.ismp.org

For registration questions, contact ProCE at 1-800-748-7795.

OverviewRadiology departments often use medications in ways that are different from other clinical areas of the hospital, and staff may not be aware of the significant safety issues that can arise. This symposium will explore current medication safety issues in the radiology setting, such the safe use of contrast, appropriate labeling of containers, beyond-use dating, and patient identification. Nationally known experts will discuss actual cases where errors have occurred and risk reduction strategies, including use of technology and best practices. A new Imaging Bulk Package for contrast recently approved by the US Food and Drug Administration (FDA) as well as regulatory and The Joint Commission accreditation requirements for use of contrast and other medications in radiology will also be discussed.

ObjectivesThe target audience for this activity includes pharmacists in health-system settings. At the completion of this symposium, the participant should be able to:

• Describe how medications and contrast agents are ordered, stored, prepared, and utilized in the radiology setting.

• Explain the difference between the new FDA classification of an imaging bulk package vs. a pharmacy bulk package of contrast, and why FDA developed this new product type.

• Identify system-based causes of medication errors associated with the use of medications and contrast agents in radiology.

• Prioritize selected strategies to prevent harm and improve medication safety in radiology.

• Describe current regulatory and accreditation requirements related to the use of medications and contrast agents in radiology, and the role of the pharmacy in assuring compliance with the standards.

Improving Medication Safety in the Radiology SettingBreakfast Symposium Monday, December 8, 2014Pacific Ballroom DHilton Anaheim

Breakfast 6:15 AM – 6:45 AMSymposium 6:45 AM – 8:45 AMSpace is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis. To register, please go to: www.ProCE.com/ISMP2014

Topics and FacultyIntroduction and Program OverviewJanice Dunsavage, RPh, MAS, Chair, ISMP Board of Trustees and Director of Pharmacy, PinnacleHealth, Harrisburg, PA

Primer on Medication Administration Systems and Medications Used in RadiologyLior Molvin, (MBA) (RT) (R) (CT), CT Protocol Technologist, CT Protocol Development and Education Team, Stanford University Medical Center and Stanford Medicine, Imaging Center, Palo Alto, CA

Medication Safety Issues and Recommended Strategies Matthew P. Fricker, Jr, MS, RPh, FASHP, Program Director, ISMP

Centers for Medicare & Medicaid Services (CMS) and The Joint Commission Requirements Darryl S. Rich, PharmD, MBA, FASHP, Medication Safety Specialist, ISMP

Question and Answer SessionJanice Dunsavage, RPh, MAS, Chair, ISMP Board of Trustees and Director of Pharmacy, PinnacleHealth, Harrisburg, PA

AccreditationThis CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-14-227-L05-P has been assigned to this knowledge-based live CE activity (initial release date December 8, 2014). This CE activity is approved for 2.0 contact hours (0.20 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 9, 2015 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor within 1 to 2 weeks of the completion of the post-test and evaluation. No partial credit will be given. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.